Biomarker Validation

The HTG Edge system enables a seamless transition from early clinical research where biomarker discovery may have been done in cell or animal models to translational medicine and clinical development where the preferred sample type is formalin-fixed, paraffin embedded (FFPE) tissue.  

HTG Molecular has developed a family of products for tumor profiling that helps validate biomarker strategy that can then be embedded in clinical trials. These products match the advantaged extraction-free HTG Edge chemistry with the easy to use the HTG Edge processor and the power of next-generation sequencing (NGS) detection technology.  

With only a single section 5 μm of FFPE tissue, these tumor profiling products can provide thousands of potentially clinically actionable biomarker results.



Learn more about HTG's Biomarker products and applications

HTG EdgeSeq miRNA Whole Transcriptome Assay WTA
HTG EdgeSeq Oncology Biomarker Panel
HTG EdgeSeq miRNA Expression Profiling
HTG EdgeSeq mRNA Expression Profiling
HTG EdgeSeq Future Applications

HTG Edge System Immuno-Oncology Expression Assay
HTG Edge System DLBCL COO Expression Assay
HTG Edge System DMPK Expression Assay

Website Section: 

Last updated: 06/10/2016 - 07:04